172 related articles for article (PubMed ID: 26646590)
1. Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
Hu Y; Ge W; Wang X; Sutendra G; Zhao K; Dedeić Z; Slee EA; Baer C; Lu X
Oncotarget; 2015 Dec; 6(40):42478-90. PubMed ID: 26646590
[TBL] [Abstract][Full Text] [Related]
2. A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells.
Li H; Zhang W; Zhao K; Zhao D; Zheng S; Hu Y
J Biol Chem; 2020 Mar; 295(12):4049-4063. PubMed ID: 32005663
[TBL] [Abstract][Full Text] [Related]
3. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
4. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.
Jeong SJ; Pise-Masison CA; Radonovich MF; Park HU; Brady JN
J Biol Chem; 2005 Mar; 280(11):10326-32. PubMed ID: 15611068
[TBL] [Abstract][Full Text] [Related]
5. Proenkephalin assists stress-activated apoptosis through transcriptional repression of NF-kappaB- and p53-regulated gene targets.
McTavish N; Copeland LA; Saville MK; Perkins ND; Spruce BA
Cell Death Differ; 2007 Sep; 14(9):1700-10. PubMed ID: 17599100
[TBL] [Abstract][Full Text] [Related]
6. miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.
Zou H; Zou R; Chen K; Zhu C; Tian X; You Y; He X
J Cell Biochem; 2018 Nov; 119(11):9217-9228. PubMed ID: 30105797
[TBL] [Abstract][Full Text] [Related]
7. A small peptide derived from p53 linker region can resume the apoptotic activity of p53 by sequestering iASPP with p53.
Qiu S; Cai Y; Gao X; Gu SZ; Liu ZJ
Cancer Lett; 2015 Jan; 356(2 Pt B):910-7. PubMed ID: 25444901
[TBL] [Abstract][Full Text] [Related]
8. Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells.
Qiu S; Liu S; Yu T; Yu J; Wang M; Rao Q; Xing H; Tang K; Mi Y; Wang J
BMC Cancer; 2017 Nov; 17(1):795. PubMed ID: 29179704
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification.
Notari M; Hu Y; Koch S; Lu M; Ratnayaka I; Zhong S; Baer C; Pagotto A; Goldin R; Salter V; Candi E; Melino G; Lu X
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16645-50. PubMed ID: 21930934
[TBL] [Abstract][Full Text] [Related]
10. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
Bergamaschi D; Samuels Y; O'Neil NJ; Trigiante G; Crook T; Hsieh JK; O'Connor DJ; Zhong S; Campargue I; Tomlinson ML; Kuwabara PE; Lu X
Nat Genet; 2003 Feb; 33(2):162-7. PubMed ID: 12524540
[TBL] [Abstract][Full Text] [Related]
11. HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth.
Pandolfi S; Montagnani V; Lapucci A; Stecca B
Cell Death Differ; 2015 Dec; 22(12):2006-19. PubMed ID: 26024388
[TBL] [Abstract][Full Text] [Related]
12. Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response.
Li Z; Niu J; Uwagawa T; Peng B; Chiao PJ
J Biol Chem; 2005 Apr; 280(17):16843-50. PubMed ID: 15671037
[TBL] [Abstract][Full Text] [Related]
13. The role of p65 NF-kappaB/RelA in pancreatitis-induced Kupffer cell apoptosis.
Peng Y; Gallagher SF; Landmann R; Haines K; Murr MM
J Gastrointest Surg; 2006 Jun; 10(6):837-47. PubMed ID: 16769540
[TBL] [Abstract][Full Text] [Related]
14. CDK9 inhibitors reactivate p53 by downregulating iASPP.
Wu J; Liang Y; Tan Y; Tang Y; Song H; Wang Z; Li Y; Lu M
Cell Signal; 2020 Mar; 67():109508. PubMed ID: 31866490
[TBL] [Abstract][Full Text] [Related]
15. Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytes.
Coiras M; López-Huertas MR; Mateos E; Alcamí J
Retrovirology; 2008 Dec; 5():109. PubMed ID: 19046417
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel isoform of iASPP and its interaction with p53.
Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling.
Qian K; Yuan L; Wang S; Kuang Y; Jin Q; Long D; Jiang Y; Zhao H; Liu K; Yao H
Clin Exp Immunol; 2021 Aug; 205(2):246-256. PubMed ID: 33942299
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
19. Enforced expression of PPP1R13L increases tumorigenesis and invasion through p53-dependent and p53-independent mechanisms.
Laska MJ; Lowe SW; Zender L; Hearn S; Vogel U; Jensen UB; Bric A; Nexø BA
Mol Carcinog; 2009 Sep; 48(9):832-42. PubMed ID: 19263435
[TBL] [Abstract][Full Text] [Related]
20. MiR-340/iASPP axis affects UVB-mediated retinal pigment epithelium (RPE) cell damage.
Yan J; Qin Y; Yu J; Peng Q; Chen X
J Photochem Photobiol B; 2018 Sep; 186():9-16. PubMed ID: 29982095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
